SecBot SecBot
425 ·Filed Sep 15, 2026

MDT

Medtronic plc
NEUTRAL
Impact 4/10
Horizonweeks Processed2mo ago SEC0001628280-26-062091
Rule 425 M&A communications
Actionable Insight • Neutral

Monitor for the next material update on the deal, such as regulatory approvals, shareholder vote dates, or revised synergy estimates. The filing is routine and promotional; no immediate trading action is warranted based on this communication alone.

DirectionNeutral
Confidencelow
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$92.60
T+0 close · Sep 15, 2026 · via day close
Latest settled
+1.76%
T+20 · $94.23 · next T+60 in 23d
Vs SPY
−0.30%
α at T+20
Latest observation
+10.04%
T+41 · FF3 residual α
  1. T+0 · Sep 16 $92.60entry
  2. T+1 · 2mo ago +0.18%α −0.95% · $92.77
  3. T+5 · 8w ago −3.56%α −6.13% · $89.30
  4. T+20 · 5w ago +1.76%α −0.30% · $94.23
  5. T+43 · todayOpen
  6. T+60 · in 23d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Medtronic plc filed a Rule 425 prospectus communication in connection with its pending business combination. The filing is promotional in nature, emphasizing the strategic rationale and expected benefits of the deal, but contains no new material financial information or changes to deal terms.

Key Financial Metrics

Deal Type
merger

Key Facts

  • Rule 425 filing in connection with a pending business combination
  • No new financial figures, deal terms, or timeline updates disclosed in the available content
  • Filing is promotional, highlighting strategic rationale and expected synergies

Financial Impact

No specific dollar amounts or percentages disclosed in the filing content.

Risk Factors

  • Deal may face regulatory or shareholder opposition not disclosed in this filing
  • Synergy estimates may be revised downward as the deal progresses

Market Snapshot

Exchange
NYSE
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
68% bullish (34 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001628280-26-062091
Document: 0001628280-26-062091-index-headers.html0001628280-26-062091
Document: 0001628280-26-062091-index.html0001628280-26-062091
Document: 0001628280-26-062091.txt0001628280-26-062091

Track record

53 reports on MDT

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +15.30% at T+60 after the Jun 3, 2026 report. 9 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Neutral 4/10 Entry price pending
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $101.59 Now $102.88 +1.27% settles Feb 8
  3. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $98.88 Now $102.88 +4.05% settles Feb 1
  4. Oct 19, 202628d ago 8-K Neutral 4/10 Entry $94.63 Now $102.88 +8.72% settles Jan 15
  5. Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
  6. Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
  7. Oct 15, 20264w ago 144 Neutral 3/10 Entry $95.45 Now $102.88 +7.78% settles Jan 12
  8. Oct 14, 20264w ago SC TO-I/A Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
  9. Oct 14, 20264w ago 425 Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
  10. Oct 13, 20264w ago SC TO-I/A Neutral 5/10 Entry $93.01 Now $102.88 +10.61% settles Jan 8
Showing 10 of 53

US Market Status

Market Closed · Opens Wed (10h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 15, 2026